One clinical study showed that pharmacological induction of CD39 alleviates pediatric colitis,142 identifying possible mechanisms by which commensals promote CD39 upregulation may prove to be a useful strategy to limit intestinal inflammation. This evidence concerns the gene ENTPD1 and colitis.